Select Page

On Thursday, October 5th, 2017, the Dan Morton Boston Area Pharmaceutical Toxicology Group meeting will be held at Kendall Square Cinema in Cambridge, MA. The morning session will be dedicated to reviewing Comprehensive in vitro Proarrhythmia Assay (CiPA) efforts. The afternoon session will focus on Cell-based Therapy and Rare diseases. SNBL USA’s Principal Scientist Dr. Mark Walker, PhD will present key insights on “Successful Development of Therapeutics for Rare and Neglected Diseases: Challenges from a CRO Perspective.”

SNBL presents at Dan Morton Pharmaceutical Group 2017